CPT code 17108 denotes destruction of a cutaneous vascular proliferative lesion larger than 50 cm², typically performed with laser modalities such as Argon, pulsed dye, or YAG. The procedure is a non‑incisional, bloodless method of treating extensive vascular lesions and is primarily delivered in outpatient dermatology settings, ambulatory surgical centers, or appropriately equipped physician offices. Nationally, this code is relevant for clinicians who manage large vascular lesions and for payers that evaluate coverage and bundling of laser-based dermatologic procedures.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the procedure, typical sites of service, and which payers are commonly involved in reimbursement decisions. The publication summarizes benchmarking considerations, common modifier usage (where provided), and how this service is categorized for claims processing. It also outlines areas where data was not provided in the input, such as associated taxonomies, specific ICD-10 diagnoses, and related codes.

This brief provides a national perspective intended for clinicians, practice managers, and billing professionals seeking a clear description of the service represented by CPT code 17108 and the payer landscape relevant to claims and coverage discussions.